Patient retrospective evaluation of change: An appropriate outcome measure for clinical trials?

被引：0
|
作者：
Fischer, D [1 ]
Stewart, AL [1 ]
Bloch, DA [1 ]
Lorig, K [1 ]
Laurent, D [1 ]
Holman, HR [1 ]
机构：
[1] Stanford Univ, Sch Med, Palo Alto, CA 94304 USA
来源：
ARTHRITIS AND RHEUMATISM | 1998年 / 41卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1177
引用
收藏
页码：S229 / S229
页数：1
相关论文
共 50 条
  • [31] ADDRESSING OUTCOME MEASURE VARIABILITY IN MYASTHENIA GRAVIS CLINICAL TRIALS
    Guptill, Jeffrey T.
    Granit, Volkan
    Habib, Ali
    Lee, Ikjae
    Ruzhansky, Katherine
    Howard, James F., Jr.
    Barnett-Tapia, Carolina
    Dimachkie, Mazen M.
    Nowak, Richard J.
    Kaminski, Henry J.
    Benatar, Michael
    MUSCLE & NERVE, 2022, 65 : S11 - S12
  • [32] Key measurement concepts and appropriate clinical outcome assessments in pediatric achondroplasia clinical trials
    Aldhouse, Natalie V. J.
    Kitchen, Helen
    Johnson, Chloe
    Marshall, Chris
    Pegram, Hannah
    Pease, Sheryl
    Collins, Sam
    Baker, Christine L.
    Beaverson, Katherine
    Crews, Chandler
    Massey, Jill
    Wyrwich, Kathleen W.
    ORPHANET JOURNAL OF RARE DISEASES, 2022, 17 (01)
  • [33] Key measurement concepts and appropriate clinical outcome assessments in pediatric achondroplasia clinical trials
    Natalie V. J. Aldhouse
    Helen Kitchen
    Chloe Johnson
    Chris Marshall
    Hannah Pegram
    Sheryl Pease
    Sam Collins
    Christine L. Baker
    Katherine Beaverson
    Chandler Crews
    Jill Massey
    Kathleen W. Wyrwich
    Orphanet Journal of Rare Diseases, 17
  • [34] Key measurement concepts and appropriate clinical outcome assessments in pediatric achondroplasia clinical trials
    Aldhouse, Natalie
    Kitchen, Helen
    Johnson, Chloe
    Marshall, Chris
    Pegram, Hannah
    Pease, Sheryl
    Collins, Sam
    Baker, Christine
    Beaverson, Katherine
    Crews, Chandler
    Wyrwich, Kathleen
    MOLECULAR GENETICS AND METABOLISM, 2021, 132 : S160 - S160
  • [35] Do clinical trials prepare to fail by failing to prepare? An examination of MS trials and recommendations for patient-reported outcome measure selection
    Hobart, Jeremy
    Chitnis, Tanuja
    Oh, Jiwon
    Burke, Laurie
    King, Miriam
    Vo, Pamela
    Vandercappellen, Jo
    Lloyd, Andrew
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2023, 76
  • [36] Recruitment index as a measure of patient recruitment activity in clinical trials
    Rojavin, MA
    CONTEMPORARY CLINICAL TRIALS, 2005, 26 (05) : 552 - 556
  • [37] A METRIC FOR THE EVALUATION OF CHANGE IN CLINICAL-TRIALS
    BROUWERS, P
    MOHR, E
    CLINICAL NEUROPHARMACOLOGY, 1989, 12 (02) : 129 - 133
  • [38] Validity and responsiveness of the patient evaluation measure as an outcome measure for carpal tunnel syndrome
    Hobby, JL
    Watts, C
    Elliot, D
    JOURNAL OF HAND SURGERY-BRITISH AND EUROPEAN VOLUME, 2005, 30B (04): : 350 - 354
  • [39] LUNG CLEARANCE INDEX AS AN OUTCOME MEASURE IN CYSTIC FIBROSIS CLINICAL TRIALS
    Ratjen, F.
    Sheridan, H.
    Lee, P.
    Song, T.
    Stone, A.
    Davies, J. C.
    PEDIATRIC PULMONOLOGY, 2011, : 282 - 283
  • [40] Examining cutaneous disease activity as an outcome measure for clinical trials in dermatomyositis
    Gaffney, Rebecca G.
    Feng, Rui
    Pearson, David R.
    Tarazi, Meera
    Werth, Victoria P.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2019, 80 (06) : 1793 - 1794
12345